NMDC Q1 Results FY26: Q1 PAT Falls 0.15% to ₹1,967.74 Crore; Revenue Up 24.47 % YoY

NMDC Q1 Results FY26: NMDC posted its Q1 results on 12th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹1,967.74 crores against revenue of ₹6,738.86 crores. During Q1 FY26, the profit decrease of the company was recorded at 0.15% YoY, and the revenue increase for the same period was 24.47%. 

NMDC Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

NMDC Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

NMDC Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• NMDC clocked Q1 FY26 consolidated revenue of ₹6,738.86 crores vs ₹5,414.19 crores. 
• On the profit front, NMDC earned a consolidated PAT of ₹1,967.74 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹1,970.77 crore. 
• Consolidated PAT fell for the first quarter of FY26, was 0.15% YoY, and revenue rose 24.47% YoY. 
• As per the standalone figures, the quarterly PAT of NMDC has decreased by 0.78%, and revenue has increased by 23.36% YoY.

NMDC Share Price Performance

On the opening bell of 11th August 2025, the shares of NMDC opened at ₹72.00 per share. However, the initial gains are wiped out as of now, and NMDC shares are trading at ₹71.95 per share, lower than their opening price. 

Considering the long-term performance, NMDC shares have yielded close to -3.85% returns in the past 1 year, and 5-year returns stand at 132.00%. Over the maximum timeframe, the NMDC share provided -33.98% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in NMDC shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Finolex Cables Q1 Results FY26: Q1 PAT Falls 33.33% to ₹162.62 Crore; Revenue Up 13.41% YoY

Abbott India Q1 Results FY26: Q1 PAT Rises 11.54% to ₹365.86 Crore; Revenue Up 11.60% YoY

Jyothy Labs Q1 Results FY26: Q1 PAT Falls 4.95% to ₹96.73 Crore; Revenue Up 1.35% YoY

Zydus Lifesciences Q1 Results FY26: Q1 PAT Rises 3.30% to ₹1,466.80 Crore; Revenue Up 5.90% YoY

Bombay Burmah Trading Q1 Results FY26: Q1 PAT Soars 8.28% to ₹240.70 Crore; Revenue Up 8.73% YoY

Alkem Laboratories Q1 Results FY26: Q1 PAT Rises 21.85% to ₹664.26 Crore; Revenue Up 11.19% YoY

Natco Pharma Q1 Results FY26: Q1 PAT Falls 28.09% to ₹480.70 Crore; Revenue Down 2.47% YoY

Hindalco Q1 Results FY26: Q1 PAT Rises 30.00% to ₹4,004.00 Crore; Revenue Up 13.00% YoY